Journey Medical Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $61.9M | $56.1M | $79.2M | $73.7M | $63.1M |
| Operating income | -$8.2M | -$13.7M | -$2.1M | -$27.5M | -$34.9M |
| Cost of revenue | $20.9M | $20.9M | $22.9M | $30.8M | $32.1M |
| Cash from operations | -$12.4M | -$9.1M | $5.2M | -$13.5M | -$2.2M |
| Capital expenditure | — | $15.0M | $5.0M | $20.0M | $0 |
| Free cash flow | — | -$24.1M | $240,000 | -$33.5M | -$2.2M |
| Total assets | $94.6M | $80.2M | $76.8M | $105.2M | $97.3M |
| Total liabilities | $62.7M | $60.2M | $56.5M | $88.2M | $55.2M |
| Total debt | $26.2M | $26.2M | $15.8M | $27.9M | — |
Shares outstanding 27.5M · Free float 26.6%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.